| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |